Europe Prostate Cancer Diagnostics Market to 2032
Overview
The Europe Prostate Cancer Diagnostics Market is expected to reach a 2,567.32 USD Million by 2032 and is projected to grow at a CAGR of 16.58% from 2025 to 2032.
Revenue, 2024 (USD Million)
984.23
Forecast, 2032 (USD Million)
2,567.32
CAGR, 2024 - 2032
16.58%
Report Coverage
Europe
Europe Prostate Cancer Diagnostics Market 2018-2032 USD Million
Europe Prostate Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 984.23 USD Million
- Projected Market Size (2032): 2,567.32 USD Million
- CAGR (2025-2032): 16.58%
Key Findings of Europe Prostate Cancer Diagnostics Market
- The Europe Prostate Cancer Diagnostics Market was valued at 984.23 USD Million in 2024.
- The Europe Prostate Cancer Diagnostics Market is likely to grow at a CAGR of 16.58% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prostatic Adenocarcinoma in Type Segment accounted for the largest share of the market with a revenue of 929.92 USD Million
- The fastest growing segment Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Stage Segment grew Fastest with a CAGR of 18.49% during the forecast period from 2024 to 2032.
Europe Prostate Cancer Diagnostics Market Scope
Europe Prostate Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Independent Diagnostic Laboratories
Product Type
- Accessories
- Instruments
- Reagents & Consumables
Diagnostics Type
- Confirmatory Tests
- Preliminary Screening Tests
Stage
- Recurrent/Advanced Prostate Cancer
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
- Localized Prostate Cancer
Sample Type
- Others
- Urine
- Tissue
- Blood
Type
- Others
- Small Cell Carcinoma
- Prostatic Adenocarcinoma
Age Group
- Pediatric
- Adult
- Geriatrics
Europe Prostate Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 984.23 USD Million |
| Market Value in 2032 | 2,567.32 USD Million |
| CAGR (2025-2032) | 16.58% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Product Type,Diagnostics Type,Stage,Sample Type,Type,Age Group |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 984.23 USD Million in 2024
- Key Country: Germany, leading in terms of revenue with value of 251.88 USD Million in 2024.
Segments and Scope
-
Europe Prostate Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 788.94 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.37 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By End User
- Independent Diagnostic Laboratories is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 658.11 USD Million in the year 2024.
- Independent Diagnostic Laboratories is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.97 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 741.39 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.13 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By Diagnostics Type
- Preliminary Screening Tests is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 755.82 USD Million in the year 2024.
- Preliminary Screening Tests is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.17 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By Stage
- Localized Prostate Cancer is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 742.28 USD Million in the year 2024.
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.28 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By Sample Type
- Blood is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 770.65 USD Million in the year 2024.
- Blood is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.94 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By Type
- Prostatic Adenocarcinoma is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 929.92 USD Million in the year 2024.
- Prostatic Adenocarcinoma is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.70 % in forecast period 2025-2032.
-
Europe Prostate Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Europe Prostate Cancer Diagnostics Market to 2032 with a revenue of 831.57 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Europe Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.87 % in forecast period 2025-2032.
Europe Prostate Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| OPKO Health, Inc. | |||
| Beckman Coulter, Inc. | |||
| Abbott | |||
| F. Hoffmann-La Roche Ltd. | |||
Europe Prostate Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Europe Prostate Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Prostate Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Product Type,Diagnostics Type,Stage,Sample Type,Type,Age Group.
Europe Prostate Cancer Diagnostics Market was valued at USD 984.23(Revenue in USD Million) in 2022.
Europe Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.58% during the forecast period of 2024 to 2032.
The Prostatic Adenocarcinoma segment is expected to dominate the Europe Prostate Cancer Diagnostics Market, holding a largest market share of 929.92 USD Million in 2024
Europe Prostate Cancer Diagnostics Market Scope
Europe Prostate Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Independent Diagnostic Laboratories
Product Type
- Accessories
- Instruments
- Reagents & Consumables
Diagnostics Type
- Confirmatory Tests
- Preliminary Screening Tests
Stage
- Recurrent/Advanced Prostate Cancer
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
- Localized Prostate Cancer
Sample Type
- Others
- Urine
- Tissue
- Blood
Type
- Others
- Small Cell Carcinoma
- Prostatic Adenocarcinoma
Age Group
- Pediatric
- Adult
- Geriatrics
Frequently Asked Questions
The Europe Prostate Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Product Type,Diagnostics Type,Stage,Sample Type,Type,Age Group.
Europe Prostate Cancer Diagnostics Market was valued at USD 984.23(Revenue in USD Million) in 2022.
Europe Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.58% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Prostate Cancer Diagnostics Market for final year is USD 2,567.32 (USD Million).
Europe Prostate Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Europe Prostate Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Product Type,Diagnostics Type,Stage,Sample Type,Type,Age Group.
Europe Prostate Cancer Diagnostics Market was valued at USD 984.23(Revenue in USD Million) in 2022.
Europe Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.58% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Prostate Cancer Diagnostics Market for final year is USD 2,567.32 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.